Nonetheless, in patients with longer thrombocytopenic duration, we found a significant increase in the percentage of CD4+ TCM. Moreover, the percentage of CD8+ TEMRA was significantly higher in ITP patients than control. The gene discussed is CD4; the disease is autoimmune thrombocytopenic purpura.